|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/12/2024 |
$0.39 |
$0.48 |
$0.36 |
$0.44 |
802.50K | 04/15/2024 |
$0.42 |
$0.44 |
$0.40 |
$0.42 |
103.60K | 04/16/2024 |
$0.43 |
$0.43 |
$0.41 |
$0.42 |
109.80K | 04/17/2024 |
$0.42 |
$0.42 |
$0.37 |
$0.40 |
108.10K | 04/18/2024 |
$0.40 |
$0.41 |
$0.27 |
$0.34 |
1.79M |
|
Windtree Therapeutics is a biopharmaceutical company focused on the development of therapeutics. Co.'s primary product candidate, istaroxime, is a dual-acting agent being developed to improve cardiac function in patients with acute heart failure. Co.'s heart failure cardiovascular portfolio also includes sarco endoplasmic reticulum Ca2+ -ATPase 2a (SERCA2a) activators. This research program is evaluating these preclinical product candidates, including oral and intravenous SERCA2a activator heart failure compounds. In addition, Co.'s cardiovascular drug product candidates include rostafuroxin, a product candidate for the treatment of hypertension in patients with a specific genetic profile. | |
|
Windtree Therapeutics (WINT) has the following price history information. Looking back at WINT historical stock prices for the last five trading days, on April 12, 2024, WINT opened at $0.39, traded as high as $0.48 and as low as $0.36, and closed at $0.44. Trading volume was a total of 802.50K shares. On April 15, 2024, WINT opened at $0.42, traded as high as $0.44 and as low as $0.40, and closed at $0.42. Trading volume was a total of 103.60K shares. On April 16, 2024, WINT opened at $0.43, traded as high as $0.43 and as low as $0.41, and closed at $0.42. Trading volume was a total of 109.80K shares. On April 17, 2024, WINT opened at $0.42, traded as high as $0.42 and as low as $0.37, and closed at $0.40. Trading volume was a total of 108.10K shares. On April 18, 2024, WINT opened at $0.40, traded as high as $0.41 and as low as $0.27, and closed at $0.34. Trading volume was a total of 1.79M shares.
WINT Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into Windtree Therapeutics shares, starting with a $10,000 purchase of WINT, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/22/2014 |
|
End date: |
04/18/2024 |
|
Start price/share: |
$99.00 |
|
End price/share: |
$0.34 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.66% |
|
Average Annual Total Return: |
-43.31% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$34.34 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/12/2024 | $0.44 | 04/15/2024 | $0.42 | 04/16/2024 | $0.42 | 04/17/2024 | $0.40 | 04/18/2024 | $0.34 |
|
|